1-2 of 2
Alexander Suvorov, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final Overall Survival Results of a Randomized Trial Comparing Bortezomib Plus Pegylated Liposomal Doxorubicin with Bortezomib Alone in Subjects with Relapsed or Refractory Multiple Myeloma

Robert Z. Orlowski, MD, PhD, Arnon Nagler, MD, Pieter Sonneveld, MDPhD, Joan Bladé, MD PhD, Roman Hajek, Andrew Spencer, MD, Tadeusz Robak, MD, Anna Dmoszynska, Noemi Horvath, MB,ChB, FRACP, FRCPA, Ivan Spicka, Heather J. Sutherland, MD PhD FRCPC, Alexander Suvorov, MD, Liang Xiu, Trilok V. Parekh, PhD, Jesús San Miguel, MD
Journal: Blood
Blood (2014) 124 (21): 3448.
https://doi.org/10.1182/blood.V124.21.3448.3448
Published: 2014
Journal Articles

QT Interval Effects and M-Protein Response in a Phase 1 Study of Siltuximab (Anti-IL-6 Monoclonal Antibody) in Patients with Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple Myeloma.

Sheeba K. Thomas, MD, Alexander Suvorov, MD, Lucien Noens, MD, PhD, Oleg Rukavitsin, MD, Joseph Fay, MD, Ka Lung Wu, MD, PhD, Todd M Zimmerman, MD, Helgi van de Velde, MD, PhD, Rajesh Bandekar, PhD, Thomas A Puchalski, PharmD, Ming Qi, MD, PhD, Clarissa Uhlar, PhD, Olga S Samoilova, MD
Journal: Blood
Blood (2012) 120 (21): 2972.
https://doi.org/10.1182/blood.V120.21.2972.2972
Published: 2012